nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0775	0.214	CbGbCtD
Topiramate—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0775	0.214	CbGbCtD
Topiramate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0494	0.136	CbGbCtD
Topiramate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0334	0.092	CbGbCtD
Topiramate—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0325	0.0897	CbGbCtD
Topiramate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0319	0.0878	CbGbCtD
Topiramate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0284	0.0782	CbGbCtD
Topiramate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0167	0.0459	CbGbCtD
Topiramate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0157	0.0433	CbGbCtD
Topiramate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000703	CcSEcCtD
Topiramate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000703	CcSEcCtD
Topiramate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.000701	CcSEcCtD
Topiramate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.000697	CcSEcCtD
Topiramate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000696	CcSEcCtD
Topiramate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000329	0.000695	CcSEcCtD
Topiramate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000694	CcSEcCtD
Topiramate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.000694	CcSEcCtD
Topiramate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000689	CcSEcCtD
Topiramate—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000686	CcSEcCtD
Topiramate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.000684	CcSEcCtD
Topiramate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.000679	CcSEcCtD
Topiramate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00032	0.000677	CcSEcCtD
Topiramate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.000677	CcSEcCtD
Topiramate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.000676	CcSEcCtD
Topiramate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000318	0.000673	CcSEcCtD
Topiramate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000673	CcSEcCtD
Topiramate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.000672	CcSEcCtD
Topiramate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00067	CcSEcCtD
Topiramate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000667	CcSEcCtD
Topiramate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000666	CcSEcCtD
Topiramate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000664	CcSEcCtD
Topiramate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.000661	CcSEcCtD
Topiramate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.000661	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00066	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00066	CcSEcCtD
Topiramate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00031	0.000655	CcSEcCtD
Topiramate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.000655	CcSEcCtD
Topiramate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.000652	CcSEcCtD
Topiramate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.000651	CcSEcCtD
Topiramate—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000648	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000306	0.000646	CcSEcCtD
Topiramate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.000645	CcSEcCtD
Topiramate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000305	0.000645	CcSEcCtD
Topiramate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.000644	CcSEcCtD
Topiramate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000304	0.000644	CcSEcCtD
Topiramate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000303	0.000641	CcSEcCtD
Topiramate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000639	CcSEcCtD
Topiramate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.000637	CcSEcCtD
Topiramate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000301	0.000637	CcSEcCtD
Topiramate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000301	0.000637	CcSEcCtD
Topiramate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0003	0.000635	CcSEcCtD
Topiramate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00063	CcSEcCtD
Topiramate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.000629	CcSEcCtD
Topiramate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.000627	CcSEcCtD
Topiramate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000296	0.000625	CcSEcCtD
Topiramate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.000625	CcSEcCtD
Topiramate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000295	0.000624	CcSEcCtD
Topiramate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000295	0.000624	CcSEcCtD
Topiramate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.000624	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000623	CcSEcCtD
Topiramate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000293	0.000619	CcSEcCtD
Topiramate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.000619	CcSEcCtD
Topiramate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000293	0.000619	CcSEcCtD
Topiramate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.000619	CcSEcCtD
Topiramate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.000618	CcSEcCtD
Topiramate—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000617	CcSEcCtD
Topiramate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000617	CcSEcCtD
Topiramate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.000614	CcSEcCtD
Topiramate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00029	0.000612	CcSEcCtD
Topiramate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000289	0.000611	CcSEcCtD
Topiramate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000609	CcSEcCtD
Topiramate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.000608	CcSEcCtD
Topiramate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000287	0.000606	CcSEcCtD
Topiramate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.000605	CcSEcCtD
Topiramate—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.000603	CcSEcCtD
Topiramate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.000602	CcSEcCtD
Topiramate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000601	CcSEcCtD
Topiramate—CA6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000284	0.00173	CbGpPWpGaD
Topiramate—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000284	0.00173	CbGpPWpGaD
Topiramate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.0006	CcSEcCtD
Topiramate—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000284	0.00173	CbGpPWpGaD
Topiramate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.000599	CcSEcCtD
Topiramate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.000598	CcSEcCtD
Topiramate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000282	0.000597	CcSEcCtD
Topiramate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.000597	CcSEcCtD
Topiramate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.000596	CcSEcCtD
Topiramate—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000282	0.00172	CbGpPWpGaD
Topiramate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000594	CcSEcCtD
Topiramate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.000593	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00028	0.00171	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.000592	CcSEcCtD
Topiramate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00028	0.000592	CcSEcCtD
Topiramate—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000592	CcSEcCtD
Topiramate—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00028	0.00171	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00059	CcSEcCtD
Topiramate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000589	CcSEcCtD
Topiramate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000585	CcSEcCtD
Topiramate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000585	CcSEcCtD
Topiramate—CA6—Metabolism—GC—chronic obstructive pulmonary disease	0.000276	0.00169	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	0.000276	0.00169	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000276	0.00168	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00058	CcSEcCtD
Topiramate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00058	CcSEcCtD
Topiramate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000575	CcSEcCtD
Topiramate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000575	CcSEcCtD
Topiramate—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000272	0.00166	CbGpPWpGaD
Topiramate—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000272	0.00166	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—chronic obstructive pulmonary disease	0.000271	0.00165	CbGpPWpGaD
Topiramate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.000572	CcSEcCtD
Topiramate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000271	0.000572	CcSEcCtD
Topiramate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000271	0.000572	CcSEcCtD
Topiramate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.000572	CcSEcCtD
Topiramate—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000571	CcSEcCtD
Topiramate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00057	CcSEcCtD
Topiramate—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000269	0.00164	CbGpPWpGaD
Topiramate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000566	CcSEcCtD
Topiramate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.000566	CcSEcCtD
Topiramate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.000565	CcSEcCtD
Topiramate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.000565	CcSEcCtD
Topiramate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000266	0.000563	CcSEcCtD
Topiramate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.000563	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000266	0.00162	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000266	0.00162	CbGpPWpGaD
Topiramate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.000562	CcSEcCtD
Topiramate—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.000562	CcSEcCtD
Topiramate—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000265	0.00162	CbGpPWpGaD
Topiramate—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000265	0.00162	CbGpPWpGaD
Topiramate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000265	0.000561	CcSEcCtD
Topiramate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000265	0.000561	CcSEcCtD
Topiramate—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00056	CcSEcCtD
Topiramate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.000559	CcSEcCtD
Topiramate—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.0016	CbGpPWpGaD
Topiramate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.000555	CcSEcCtD
Topiramate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000553	CcSEcCtD
Topiramate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.000552	CcSEcCtD
Topiramate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000549	CcSEcCtD
Topiramate—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000258	0.00157	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000258	0.00157	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000258	0.00157	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000257	0.00157	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000257	0.00157	CbGpPWpGaD
Topiramate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000543	CcSEcCtD
Topiramate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00054	CcSEcCtD
Topiramate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00054	CcSEcCtD
Topiramate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.000533	CcSEcCtD
Topiramate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000252	0.000533	CcSEcCtD
Topiramate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000252	0.000533	CcSEcCtD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.00154	CbGpPWpGaD
Topiramate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.000532	CcSEcCtD
Topiramate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000528	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000248	0.00151	CbGpPWpGaD
Topiramate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000247	0.000522	CcSEcCtD
Topiramate—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000246	0.0015	CbGpPWpGaD
Topiramate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.000519	CcSEcCtD
Topiramate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000246	0.000519	CcSEcCtD
Topiramate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000242	0.000512	CcSEcCtD
Topiramate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.000512	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000242	0.00148	CbGpPWpGaD
Topiramate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000511	CcSEcCtD
Topiramate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000511	CcSEcCtD
Topiramate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000241	0.000509	CcSEcCtD
Topiramate—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00024	0.00146	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00024	0.00146	CbGpPWpGaD
Topiramate—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000239	0.00146	CbGpPWpGaD
Topiramate—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.000239	0.00146	CbGpPWpGaD
Topiramate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000504	CcSEcCtD
Topiramate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.000504	CcSEcCtD
Topiramate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000237	0.000502	CcSEcCtD
Topiramate—SCN1A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000235	0.00143	CbGpPWpGaD
Topiramate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000495	CcSEcCtD
Topiramate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000495	CcSEcCtD
Topiramate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000491	CcSEcCtD
Topiramate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00049	CcSEcCtD
Topiramate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000488	CcSEcCtD
Topiramate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000229	0.000485	CcSEcCtD
Topiramate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.000484	CcSEcCtD
Topiramate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00048	CcSEcCtD
Topiramate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000226	0.000479	CcSEcCtD
Topiramate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.000479	CcSEcCtD
Topiramate—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000225	0.00137	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00136	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000222	0.00136	CbGpPWpGaD
Topiramate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000469	CcSEcCtD
Topiramate—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000469	CcSEcCtD
Topiramate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000468	CcSEcCtD
Topiramate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000461	CcSEcCtD
Topiramate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00046	CcSEcCtD
Topiramate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00046	CcSEcCtD
Topiramate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000456	CcSEcCtD
Topiramate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000456	CcSEcCtD
Topiramate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000456	CcSEcCtD
Topiramate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000456	CcSEcCtD
Topiramate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000456	CcSEcCtD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.00131	CbGpPWpGaD
Topiramate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.000454	CcSEcCtD
Topiramate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000215	0.000454	CcSEcCtD
Topiramate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000453	CcSEcCtD
Topiramate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000453	CcSEcCtD
Topiramate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000452	CcSEcCtD
Topiramate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000452	CcSEcCtD
Topiramate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000451	CcSEcCtD
Topiramate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000447	CcSEcCtD
Topiramate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000447	CcSEcCtD
Topiramate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.000446	CcSEcCtD
Topiramate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000445	CcSEcCtD
Topiramate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00021	0.000444	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.00021	0.00128	CbGpPWpGaD
Topiramate—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000438	CcSEcCtD
Topiramate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000435	CcSEcCtD
Topiramate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000433	CcSEcCtD
Topiramate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000432	CcSEcCtD
Topiramate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000431	CcSEcCtD
Topiramate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000431	CcSEcCtD
Topiramate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000431	CcSEcCtD
Topiramate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00043	CcSEcCtD
Topiramate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00043	CcSEcCtD
Topiramate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.000428	CcSEcCtD
Topiramate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000422	CcSEcCtD
Topiramate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000199	0.000421	CcSEcCtD
Topiramate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.00121	CbGpPWpGaD
Topiramate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000416	CcSEcCtD
Topiramate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000415	CcSEcCtD
Topiramate—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000196	0.0012	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.00118	CbGpPWpGaD
Topiramate—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000408	CcSEcCtD
Topiramate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000406	CcSEcCtD
Topiramate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.000404	CcSEcCtD
Topiramate—CA4—Metabolism—GC—chronic obstructive pulmonary disease	0.000191	0.00116	CbGpPWpGaD
Topiramate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000191	0.00116	CbGpPWpGaD
Topiramate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000403	CcSEcCtD
Topiramate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000401	CcSEcCtD
Topiramate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000399	CcSEcCtD
Topiramate—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000188	0.00115	CbGpPWpGaD
Topiramate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000394	CcSEcCtD
Topiramate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.000392	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000185	0.00113	CbGpPWpGaD
Topiramate—CA2—Metabolism—GC—chronic obstructive pulmonary disease	0.000183	0.00111	CbGpPWpGaD
Topiramate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000386	CcSEcCtD
Topiramate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000383	CcSEcCtD
Topiramate—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00018	0.0011	CbGpPWpGaD
Topiramate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000379	CcSEcCtD
Topiramate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000375	CcSEcCtD
Topiramate—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000177	0.00108	CbGpPWpGaD
Topiramate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000372	CcSEcCtD
Topiramate—CA1—Metabolism—GC—chronic obstructive pulmonary disease	0.000175	0.00107	CbGpPWpGaD
Topiramate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000364	CcSEcCtD
Topiramate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000362	CcSEcCtD
Topiramate—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00017	0.00104	CbGpPWpGaD
Topiramate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000355	CcSEcCtD
Topiramate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000354	CcSEcCtD
Topiramate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000352	CcSEcCtD
Topiramate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000351	CcSEcCtD
Topiramate—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000165	0.00101	CbGpPWpGaD
Topiramate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000349	CcSEcCtD
Topiramate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000349	CcSEcCtD
Topiramate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000164	0.000997	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000163	0.000997	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000163	0.000994	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.000975	CbGpPWpGaD
Topiramate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000335	CcSEcCtD
Topiramate—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000158	0.000966	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.000962	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.000955	CbGpPWpGaD
Topiramate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000329	CcSEcCtD
Topiramate—CA9—Metabolism—GC—chronic obstructive pulmonary disease	0.000154	0.00094	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000153	0.000934	CbGpPWpGaD
Topiramate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000324	CcSEcCtD
Topiramate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000323	CcSEcCtD
Topiramate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000323	CcSEcCtD
Topiramate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000321	CcSEcCtD
Topiramate—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000151	0.000921	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000151	0.000921	CbGpPWpGaD
Topiramate—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000149	0.00091	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000149	0.00091	CbGpPWpGaD
Topiramate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000315	CcSEcCtD
Topiramate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000314	CcSEcCtD
Topiramate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000313	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000148	0.0009	CbGpPWpGaD
Topiramate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000311	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000147	0.000896	CbGpPWpGaD
Topiramate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000307	CcSEcCtD
Topiramate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.000876	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000143	0.000873	CbGpPWpGaD
Topiramate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000302	CcSEcCtD
Topiramate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000301	CcSEcCtD
Topiramate—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000141	0.00086	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000141	0.00086	CbGpPWpGaD
Topiramate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000297	CcSEcCtD
Topiramate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000297	CcSEcCtD
Topiramate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000296	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000295	CcSEcCtD
Topiramate—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000139	0.00085	CbGpPWpGaD
Topiramate—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000139	0.00085	CbGpPWpGaD
Topiramate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000294	CcSEcCtD
Topiramate—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000138	0.00084	CbGpPWpGaD
Topiramate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000289	CcSEcCtD
Topiramate—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000136	0.000831	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000136	0.000831	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000136	0.000831	CbGpPWpGaD
Topiramate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000285	CcSEcCtD
Topiramate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000283	CcSEcCtD
Topiramate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00028	CcSEcCtD
Topiramate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000279	CcSEcCtD
Topiramate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000278	CcSEcCtD
Topiramate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000277	CcSEcCtD
Topiramate—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000131	0.000796	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.00013	0.000795	CbGpPWpGaD
Topiramate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000275	CcSEcCtD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00079	CbGpPWpGaD
Topiramate—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000129	0.000787	CbGpPWpGaD
Topiramate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000272	CcSEcCtD
Topiramate—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000127	0.000776	CbGpPWpGaD
Topiramate—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000127	0.000776	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.000765	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.000765	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000124	0.000759	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00026	CcSEcCtD
Topiramate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000259	CcSEcCtD
Topiramate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000258	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000122	0.000742	CbGpPWpGaD
Topiramate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000256	CcSEcCtD
Topiramate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000251	CcSEcCtD
Topiramate—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000118	0.000718	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.000715	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.000715	CbGpPWpGaD
Topiramate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000248	CcSEcCtD
Topiramate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000247	CcSEcCtD
Topiramate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000247	CcSEcCtD
Topiramate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000246	CcSEcCtD
Topiramate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000246	CcSEcCtD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.000708	CbGpPWpGaD
Topiramate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000244	CcSEcCtD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.000699	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.000698	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.000689	CbGpPWpGaD
Topiramate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000235	CcSEcCtD
Topiramate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000233	CcSEcCtD
Topiramate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000233	CcSEcCtD
Topiramate—SCN1A—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.00011	0.00067	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.000662	CbGpPWpGaD
Topiramate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000226	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000107	0.00065	CbGpPWpGaD
Topiramate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000225	CcSEcCtD
Topiramate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000225	CcSEcCtD
Topiramate—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000105	0.000638	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000105	0.000638	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000104	0.000635	CbGpPWpGaD
Topiramate—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000103	0.00063	CbGpPWpGaD
Topiramate—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000103	0.00063	CbGpPWpGaD
Topiramate—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000103	0.000628	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000101	0.000616	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.99e-05	0.000609	CbGpPWpGaD
Topiramate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.00021	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	9.88e-05	0.000603	CbGpPWpGaD
Topiramate—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.87e-05	0.000602	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	9.87e-05	0.000602	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.77e-05	0.000596	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.77e-05	0.000596	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.69e-05	0.000591	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.68e-05	0.000591	CbGpPWpGaD
Topiramate—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000204	CcSEcCtD
Topiramate—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.64e-05	0.000588	CbGpPWpGaD
Topiramate—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.64e-05	0.000588	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.62e-05	0.000587	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.62e-05	0.000587	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.57e-05	0.000584	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.55e-05	0.000582	CbGpPWpGaD
Topiramate—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.53e-05	0.000202	CcSEcCtD
Topiramate—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.46e-05	0.000577	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.42e-05	0.000574	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.42e-05	0.000574	CbGpPWpGaD
Topiramate—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.4e-05	0.000573	CbGpPWpGaD
Topiramate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.22e-05	0.000195	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	9.17e-05	0.000559	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.12e-05	0.000556	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.12e-05	0.000556	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.05e-05	0.000552	CbGpPWpGaD
Topiramate—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.01e-05	0.000549	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.98e-05	0.000548	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.98e-05	0.000548	CbGpPWpGaD
Topiramate—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.93e-05	0.000544	CbGpPWpGaD
Topiramate—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000188	CcSEcCtD
Topiramate—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	8.88e-05	0.000541	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.78e-05	0.000535	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.66e-05	0.000528	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.66e-05	0.000528	CbGpPWpGaD
Topiramate—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.64e-05	0.000527	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.61e-05	0.000525	CbGpPWpGaD
Topiramate—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.000181	CcSEcCtD
Topiramate—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.51e-05	0.000519	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.51e-05	0.000519	CbGpPWpGaD
Topiramate—Rash—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00018	CcSEcCtD
Topiramate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000179	CcSEcCtD
Topiramate—Headache—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000178	CcSEcCtD
Topiramate—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.42e-05	0.000513	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.37e-05	0.00051	CbGpPWpGaD
Topiramate—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.32e-05	0.000507	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.32e-05	0.000507	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.32e-05	0.000507	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.3e-05	0.000506	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.29e-05	0.000505	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.21e-05	0.0005	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.2e-05	0.0005	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.19e-05	0.000499	CbGpPWpGaD
Topiramate—Nausea—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000169	CcSEcCtD
Topiramate—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.96e-05	0.000485	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.89e-05	0.000481	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.84e-05	0.000478	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	7.72e-05	0.000471	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.66e-05	0.000467	CbGpPWpGaD
Topiramate—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.59e-05	0.000463	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	7.47e-05	0.000455	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.22e-05	0.00044	CbGpPWpGaD
Topiramate—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.12e-05	0.000434	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	7.04e-05	0.000429	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.03e-05	0.000429	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.99e-05	0.000427	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	6.94e-05	0.000423	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.92e-05	0.000422	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.89e-05	0.00042	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	6.83e-05	0.000417	CbGpPWpGaD
Topiramate—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.83e-05	0.000416	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	6.82e-05	0.000416	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.79e-05	0.000414	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.69e-05	0.000408	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.69e-05	0.000408	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.64e-05	0.000405	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.63e-05	0.000405	CbGpPWpGaD
Topiramate—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.54e-05	0.000399	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.46e-05	0.000394	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.36e-05	0.000388	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.34e-05	0.000386	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.29e-05	0.000384	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	6.24e-05	0.000381	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	6.2e-05	0.000378	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	6.2e-05	0.000378	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.1e-05	0.000372	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	6.03e-05	0.000368	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.03e-05	0.000368	CbGpPWpGaD
Topiramate—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.93e-05	0.000362	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.93e-05	0.000362	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.83e-05	0.000356	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	5.79e-05	0.000353	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	5.79e-05	0.000353	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.78e-05	0.000353	CbGpPWpGaD
Topiramate—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.75e-05	0.000351	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.74e-05	0.00035	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.67e-05	0.000346	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.66e-05	0.000345	CbGpPWpGaD
Topiramate—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.54e-05	0.000338	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	5.54e-05	0.000338	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	5.51e-05	0.000336	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.36e-05	0.000327	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	5.36e-05	0.000327	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.000322	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.2e-05	0.000317	CbGpPWpGaD
Topiramate—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	5.13e-05	0.000313	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.08e-05	0.00031	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.03e-05	0.000307	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5e-05	0.000305	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.95e-05	0.000302	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.000301	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.87e-05	0.000297	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.8e-05	0.000293	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.77e-05	0.000291	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.6e-05	0.00028	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.54e-05	0.000277	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.45e-05	0.000272	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.43e-05	0.00027	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.4e-05	0.000268	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.31e-05	0.000263	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	4.28e-05	0.000261	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.24e-05	0.000259	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	4.1e-05	0.00025	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.09e-05	0.000249	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.02e-05	0.000245	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.02e-05	0.000245	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.01e-05	0.000245	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	3.93e-05	0.00024	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.92e-05	0.000239	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.76e-05	0.000229	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	3.45e-05	0.000211	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.42e-05	0.000209	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.3e-05	0.000202	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.000195	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000163	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.59e-05	0.000158	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.41e-05	0.000147	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.36e-05	0.000144	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.33e-05	0.000142	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.17e-05	0.000132	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.13e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.96e-05	0.000119	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.63e-05	9.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.61e-05	9.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.5e-05	9.15e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	8.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	8.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	8.54e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	7.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	7.18e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.82e-06	5.99e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.69e-06	5.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	9.67e-06	5.9e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	9.25e-06	5.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.03e-06	5.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.56e-06	5.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.82e-06	3.55e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.56e-06	3.39e-05	CbGpPWpGaD
